期刊文献+

疏肝补肾安神汤结合西药治疗更年期抑郁症48例临床观察 被引量:4

Clinical Effect of Shugan Bushen Anshen Decoction Combined with Western Medicine for Menopausal Depression:An Observation of 48 Cases
下载PDF
导出
摘要 目的:观察中西医结合治疗更年期抑郁症的临床疗效。方法:将更年期抑郁症患者96例按随机数字表法分为2组各48例。2组均给予尼尔雌醇和帕罗西汀,观察组加用疏肝补肾安神汤治疗。4周为1疗程,均治疗2疗程。比较2组临床疗效和汉密尔顿抑郁症状评定量表(HAMD)评分变化情况。结果:总有效率观察组85.4%,对照组68.7%,2组比较,差异有显著性意义(P<0.05)。2组治疗后HAMD评分比较,差异有显著性意义(P<0.05)。结论:中西医结合治疗更年期抑郁症临床疗效显著,值得推广使用。 Objective: To inves tigate the clinical efficacy of Shugan Bushen Anshen decoction combined with wes tern medicine for menopaus al depres s ion. Methods:Ninety- s ix cas es of menopaus al depres s ion patients were randomly divided into obs ervation group and control group,48 cas es in each group. Patients of both groups received oral us e of nyles triol and paroxetine,and the obs ervation group was given Shugan Bushen Anshen decoction additionally. The treatment las ted 2 cours es covering 8 weeks. Clinical efficacy and s cores of Hamilton rating s cale for depres s ion(HAMD) were obs erved before and after treatment. Results:The total effective rate was 85.4% in the obs ervation group,and was 68.7% in the control group,the difference being s ignificant(P 0.05). After treatment, the difference of HAMD s cores between the two groups were s ignificant(P〈0.05). Conclusion:Shugan Bushen Anshen decoction combined with wes tern medicine is effective for menopaus al depres s ion,and is expected for extens ive clinical us e.
作者 谢有权
出处 《新中医》 CAS 2014年第6期137-138,共2页 New Chinese Medicine
关键词 更年期抑郁症 疏肝补肾安神汤 中西医结合疗法 Menopaus e depres s ion Shugan Bushen Anshen decoction Integrated Chines e and wes tern medicine therapy
  • 相关文献

参考文献2

二级参考文献21

  • 1陈静,陆峥,江三多,蔡军,钱伊萍,李霞.细胞色素P450酶1A2和2C19基因多态性与难治性抑郁症的关联分析[J].上海精神医学,2005,17(2):95-98. 被引量:11
  • 2符少剑,李诗南,宋玉萍,黄昭信.七叶神安片治疗广泛性焦虑障碍自身对照研究[J].广东药学院学报,1995,11(1):54-54. 被引量:4
  • 3张华,李海波,王继伟.抑郁症中医研究概况[J].中医杂志,2006,47(11):868-870. 被引量:15
  • 4秦天星,郭细先,曾德志,樊学文.解郁安神汤合利培酮治疗慢性精神分裂症的疗效与安全性研究[J].现代中西医结合杂志,2007,16(18):2492-2493. 被引量:7
  • 5沈渔邨.精神病学[M].5版.北京:人民卫生出版社.2009:838.
  • 6郝伟,于欣,徐一峰.精神科疾病临床诊疗规范教程[M].北京:北京大学医学出版社,2009:4-5.
  • 7[1]World heath and Abeles N.Late-life depression:detection,risk reduction,and somatic interventionf[J].Clinical Psychology,2005,12:207-217.
  • 8[2]Depression Guideline Panel.Clinical Practice Guideline 5:Depression in Primary Care,vol 2:Treatment of Major Depression[S].Rockvi lle,Md,US Department of Health and Human Services,Public Health Service,Agency for Health Care Policy and Research,1993.
  • 9[3]Kirsch I,Moore TJ,Scoboria A,et al.The emperor'S new drugs:an analysis of antidepressant medication data submitted to the U.S Food and Drug Administration.Prevention and Treatment[EB/OL].http:www.content.apa.org.journals.pre/5/1/23,2006-11-30.
  • 10[4]Melartin TK,Rytsala HJ,Leskela US,et al.Continuity is the main challenge in treating major depressive disorder in psychiatric care[J].Clin Psychiatry,2005,66(2):220-227.

共引文献16

同被引文献86

引证文献4

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部